Added to YB: 2024-07-18
Pitch date: 2024-07-18
ATYR:US [bullish]
aTyr Pharma, Inc.
-56.08%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
Market Cap
$73.8M
Pitch Price
$1.67
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.06
P/E
-0.89
EV/Sales
-22.27
Sector
Biotechnology
Category
N/A
Show full summary:
aTyr Pharma, Inc. ATYR:US
A summary for this pitch has not been created yet.
Read full article (0 min)